≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

EFO Endpoint Browser PheWeb

AB1_VIRAL_SKIN_NOS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B08, B09
  • Hospital discharge: ICD-9 — 057
  • Hospital discharge: ICD-8 — 057
  • Cause of death: ICD-10 — B08, B09
  • Cause of death: ICD-9 — 057
  • Cause of death: ICD-8 — 057

2 out of 7 registries used, show all original rules.

1511

4. Check minimum number of events

None

1511

5. Include endpoints

None

1511

6. Filter based on genotype QC (FinnGen only)

1511

Control definitions (FinnGen only)

Control exclude
AB1_VIRAL_SKIN_MUCOUS_MEMBRANE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 28589 13897 14649
Only index persons 18938 9296 9642
Unadjusted period prevalence (%)
Whole population 0.40 0.40 0.41
Only index persons 0.36 0.34 0.37
Median age at first event (years)
Whole population 2.18 2.31 1.97
Only index persons 2.76 3.27 2.27

-FinnGen-

Key figures

All Female Male
Number of individuals 1511 934 577
Unadjusted period prevalence (%) 0.29 0.32 0.25
Median age at first event (years) 9.76 9.04 10.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1337
Matched controls
13367
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
05710
ICD-8 Finland
Other viral exanthem, Exanthema subitum (sixth disease)
+∞
254.5
236
*
B08.1
ICD-10 Finland
Molluscum contagiosum
113.5
240.3
257
28
B08.4
ICD-10 Finland
Enteroviral vesicular stomatitis with exanthem
59.9
177.5
208
41
B09
ICD-10 Finland
Unspecified viral infection characterized by skin and mucous membrane lesions
243.7
130.4
132
6
0578A
ICD-9 Finland
Other viral exanthemata, Other specified viral exanthemata[EXANTHEMA SUBITUM]
+∞
120.7
114
*
0579X
ICD-9 Finland
Other viral exanthemata, Viral exanthem, unspecified
+∞
58.8
56
*
B08.8
ICD-10 Finland
Other specified viral infections characterized by skin and mucous membrane lesions
+∞
58.8
56
*
B08.2
ICD-10 Finland
Exanthema subitum [sixth disease]
72.0
54.6
62
9
05799
ICD-8 Finland
Other viral exanthem, Unspecified
+∞
51.4
49
*
B08.3
ICD-10 Finland
Erythema infectiosum [fifth disease]
110.3
49.1
53
5
H03.1*B08.1
ICD-10 Finland
Involvement of eyelid in molluscum contagiosum
+∞
44.0
42
*
B08.5
ICD-10 Finland
Enteroviral vesicular pharyngitis
31.7
30.5
40
13
R50.9
ICD-10 Finland
Fever, unspecified
2.4
26.2
252
1177
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.5
25.4
124
376
05797
ICD-8 Finland
Other viral exanthem, Suspecta
+∞
24.0
23
*
H02AB06
ATC
prednisolone; systemic
1.8
21.8
511
3393
127
Kela drug reimbursment
Transplant complication
9.0
19.9
42
48
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
7.7
19.5
45
60
B07.9
ICD-10 Finland
Verruca simplex
5.4
19.1
58
112
L04AD01
ATC
ciclosporin; systemic
6.7
17.0
43
66
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
16.2
193
982
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
3.7
15.9
71
201
J01DB01
ATC
cefalexin; oral
1.7
15.7
1033
8884
J01DA01
ATC
[U] cefalexin; systemic
1.6
15.7
718
5602
0578X
ICD-9 Finland
Other viral exanthemata, Other specified viral exanthemata[EXANTHEMA VIROGENA ALIA]
+∞
15.6
15
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
15.5
402
2690
J01FA10
ATC
azithromycin; systemic
1.6
14.8
820
6670
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
14.4
220
1233
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
14.2
84
295
D07AB08
ATC
desonide; topical
2.2
13.7
148
722
H02AB09
ATC
hydrocortisone; systemic
3.8
13.4
56
151
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.1
13.3
167
867
J05AB01
ATC
aciclovir; systemic
1.9
13.1
224
1305
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
12.8
73
249
L04AX01
ATC
azathioprine; systemic
3.0
12.8
75
262
E0000UV
ATC
NA
1.6
12.8
516
3834
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
12.7
740
5985
ZX120
NOMESCO Finland
Intravenous
2.4
12.7
111
486
D07AC01
ATC
betamethasone; topical
1.7
12.6
345
2321
A02BC02
ATC
pantoprazole; systemic
1.5
12.3
600
4650
L04AA06
ATC
mycophenolic acid; systemic
5.8
12.3
34
60
N02AX02
ATC
tramadol; systemic, rectal
1.6
12.0
366
2531
J05AB11
ATC
valaciclovir; oral
2.1
12.0
138
690
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
4.0
11.8
47
122
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
11.8
204
1189
L04AA01
ATC
[U] ciclosporin; systemic
9.0
11.8
24
27
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
11.5
417
2999
137
Kela drug reimbursment
Uraemia requiring dialysis
9.3
11.5
23
25
ZXE00
NOMESCO Finland
One hour or less
1.5
11.4
476
3542
J01CA04
ATC
amoxicillin; systemic
1.7
11.1
1118
10095
J01AA02
ATC
doxycycline; systemic
1.5
11.0
766
6350
N02BE01
ATC
paracetamol; systemic, rectal
1.5
11.0
942
8164
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.1
11.0
21
21
B02.9
ICD-10 Finland
Zoster without complication
4.0
10.9
43
111
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
3.3
10.8
53
164
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
10.7
221
1365
A02BC01
ATC
omeprazole; systemic
1.7
10.6
249
1598
B34.9
ICD-10 Finland
Viral infection, unspecified
2.6
10.2
72
283
Z94.0
ICD-10 Finland
Kidney transplant status
6.3
10.2
26
42
R06AE07
ATC
cetirizine; oral
1.5
10.2
548
4282
C03CA01
ATC
furosemide; systemic
1.9
10.1
146
799
M01AE02
ATC
naproxen; oral, rectal
1.4
9.9
689
5658
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
9.9
135
725
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.2
9.8
103
495
Z49.2
ICD-10 Finland
Other dialysis
8.8
9.8
20
23
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
9.7
61
223
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
9.7
193
1174
J01FF01
ATC
clindamycin; systemic
1.6
9.5
268
1798
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
2.0
9.5
120
623
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
9.4
445
3368
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.9
9.4
133
722
TQW00
NOMESCO Finland
Removal of molluscum
+∞
9.4
9
*
B05DA
ATC
Isotonic solutions
9.6
9.3
18
19
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
5.9
9.1
24
41
J01MA02
ATC
ciprofloxacin; systemic
1.5
8.9
333
2392
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.2
8.8
87
409
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
9.5
8.8
17
18
A12AA04
ATC
calcium carbonate; oral
5.4
8.8
25
47
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.4
8.7
30
69
L30.3
ICD-10 Finland
Infective dermatitis
3.3
8.7
41
125
L03AA02
ATC
filgrastim; parenteral
4.7
8.4
27
58
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
8.4
362
2674
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
8.4
184
1153
E000001
ATC
NA
1.6
8.3
268
1855
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
8.3
64
266
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
8.3
234
1568
7803A
ICD-9 Finland
General symptoms, Convulsions
3.8
8.3
33
88
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.6
8.2
27
60
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
8.2
236
1591
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
8.2
300
2142
201
Kela drug reimbursment
Chronic cardiac insufficiency
3.6
8.1
35
100
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
5.1
8.0
24
48
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
8.0
297
2122
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
8.0
193
1240
H02AB04
ATC
methylprednisolone; systemic
1.8
8.0
129
733
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.9
666
5572
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
6.6
7.9
19
29
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
7.9
556
4508
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
7.8
165
1021
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.4
7.8
27
63
XW000
NOMESCO Finland
Bone marrow biopsy
3.3
7.8
38
119
4451
FHL
Guitar cutting
2.1
7.8
84
410
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
9.5
7.8
15
16
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
7.8
311
2258
A11CC03
ATC
alfacalcidol; systemic
3.9
7.8
30
78
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
3.1
7.7
40
132
J04.0
ICD-10 Finland
Acute laryngitis
2.2
7.7
76
358
H66.9
ICD-10 Finland
Otitis media, unspecified
1.7
7.6
151
918
K06.18
ICD-10 Finland
Another gingival hyperplasia
8.9
7.5
15
17
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
7.5
118
666
602
Kela drug reimbursment
Children's severe malnutrition
4.2
7.5
27
66
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
7.5
105
571
B01.9
ICD-10 Finland
Varicella without complication
6.5
7.4
18
28
L51.9
ICD-10 Finland
Erythema multiforme, unspecified
13.4
7.4
12
9
R01AD08
ATC
fluticasone; nasal
1.5
7.4
315
2318
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
7.3
78
377
R05
ICPC
Cough
1.5
7.3
278
1993
B05DB
ATC
Hypertonic solutions
9.4
7.3
14
15
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
4.5
7.3
24
54
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
2.6
7.2
50
195
Z3231
NOMESCO Finland
Registered nurse
1.5
7.2
311
2289
UJF32
NOMESCO Finland
Coloscopy
1.6
7.2
188
1232
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.1
7.2
77
376
XF602
NOMESCO Finland
Bloodpressure monitoring
5.3
7.1
20
38
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
7.1
88
458
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
7.1
378
2902
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
8.8
7.0
14
16
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
7.0
283
2057
WX110
NOMESCO Finland
Local anesthesy
1.4
6.9
881
7817
ZXC50
NOMESCO Finland
Cryotherapy
4.4
6.8
23
53
N05CF01
ATC
zopiclone; oral
1.5
6.8
243
1715
SPAT1263
SPAT
Sampling
1.4
6.8
510
4144
B01AB05
ATC
enoxaparin; parenteral
1.5
6.8
214
1467
R03AC02
ATC
salbutamol; inhalant
1.4
6.7
630
5306
J01FA09
ATC
clarithromycin; systemic
1.4
6.7
343
2604
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.7
6.6
152
962
E000006
ATC
NA
2.0
6.6
76
383
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
6.6
201
1370
6BA02
NOMESCO Finland
NA
7.8
6.6
14
18
ZXD05
NOMESCO Finland
Urgent procedure
1.4
6.6
349
2670
C03DA01
ATC
spironolactone; oral
2.2
6.5
64
302
C07AB07
ATC
bisoprolol; oral
1.5
6.5
274
2003
D07AA02
ATC
hydrocortisone; topical
1.5
6.5
204
1401
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
6.5
81
422
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
6.5
85
452
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.3
6.4
30
93
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
6.4
37
131
UDC00
NOMESCO Finland
Ear microscopy
1.9
6.4
84
445
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
6.4
151
966
P01BA02
ATC
hydroxychloroquine; oral
2.0
6.4
72
362
M03BX02
ATC
tizanidine; oral
1.3
6.4
618
5219
D07AC13
ATC
mometasone; topical
1.5
6.3
273
2006
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
6.0
6.3
16
27
ZX112
NOMESCO Finland
Subcutaneous
3.9
6.3
24
63
A02BC05
ATC
esomeprazole; systemic
1.4
6.3
336
2573
05700
ICD-8 Finland
Other viral exanthem, Erythema infectiosum (fifth disease)
+∞
6.3
6
*
H03.1*B02.3
ICD-10 Finland
Zoster blepharitis
+∞
6.3
6
*
J02AC01
ATC
fluconazole; systemic
1.4
6.2
414
3291
G44.2
ICD-10 Finland
Tension-type headache
1.6
6.2
145
925
R01AD09
ATC
mometasone; nasal
1.3
6.1
521
4307
Z94.4
ICD-10 Finland
Liver transplant status
10.1
6.0
11
11
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.2
6.0
55
252

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
92
233
4.14
32.83
9.2
7.2
iu/ml
299.1
866.6
0.52
14
32
(42870588) Differential panel, method unspecified - Blood
601
4086
1.78
24.87
10.0
6.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
847
6359
1.76
24.70
10.7
6.9
e9/l
0.2
0.2
0.11
766
5611
(3001604) Monocytes [#/volume] in Blood
823
6139
1.75
24.46
10.3
6.5
e9/l
0.6
0.6
2.60
731
5309
(3006315) Basophils [#/volume] in Blood
824
6154
1.75
24.33
10.4
6.5
e9/l
0.0
0.0
1.30
732
5321
(3019198) Lymphocytes [#/volume] in Blood
843
6401
1.72
22.86
10.3
6.4
e9/l
2.1
2.1
0.34
765
5666
(3022096) Basophils/100 leukocytes in Blood
765
5663
1.71
22.73
10.4
6.6
%
0.6
0.7
0.18
725
5349
(3006504) Eosinophils/100 leukocytes in Blood
783
5854
1.70
22.25
10.4
6.4
%
2.8
2.9
0.22
742
5506
(3019069) Monocytes/100 leukocytes in Blood
787
5908
1.69
21.88
10.6
6.6
%
8.3
8.2
0.75
748
5599
(3013650) Neutrophils [#/volume] in Blood by Automated count
886
6945
1.67
20.19
13.6
9.0
e9/l
4.0
3.9
1.07
786
6020
(3002030) Lymphocytes/100 leukocytes in Blood
806
6170
1.66
20.12
10.3
6.4
%
30.3
31.2
1.45
769
5841
(3018010) Neutrophils/100 leukocytes in Blood
797
6094
1.65
19.91
9.9
6.2
%
55.4
54.5
1.11
759
5782
(3024561) Albumin [Mass/volume] in Serum or Plasma
557
3895
1.68
19.64
7.1
5.2
g/l
37.0
37.1
0.10
527
3644
(3030467) Casts [#/volume] in Urine by Automated count
446
2940
1.73
19.54
4.6
3.0
e6/l
0.1
0.4
4.58
344
2149
(36304419) Bacteria [Presence] in Urine
445
2949
1.72
19.04
4.5
3.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
349
2166
1.79
18.74
3.7
2.5
e6/l
7.1
7.6
0.18
318
1883
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
527
3670
1.67
18.66
5.1
3.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
180
901
2.13
18.20
5.2
4.6
u/l
238.3
254.9
0.80
175
856
(3023368) Bacteria identified in Blood by Culture
355
2237
1.77
18.02
5.6
3.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
733
5581
1.61
17.91
13.4
8.7
e9/l
0.0
0.0
0.56
598
4458
(3002582) Erythrocytes [#/volume] in Urine
465
3225
1.64
16.27
4.9
3.1
e6/l
71.2
66.7
0.03
369
2402
(3031040) Bacteria [#/volume] in Urine by Automated count
927
7560
1.59
16.22
5.3
3.8
e6/l
83.1
991.4
1.40
14
94
(3032080) INR in Blood by Coagulation assay
461
3196
1.64
16.13
8.4
6.0
inr
1.2
1.1
1.00
180
1017
(3002179) Metamyelocytes/100 leukocytes in Blood
155
771
2.13
15.88
5.2
4.1
%
0.3
0.5
0.73
35
155
(3018095) Leukocytes [#/volume] in Urine
549
3984
1.59
15.85
5.6
3.6
e6/l
60.5
78.2
0.30
395
2604
(3015377) Calcium [Moles/volume] in Serum or Plasma
441
3036
1.64
15.81
3.4
2.9
mmol/l
2.4
2.4
0.30
402
2738
(3017181) Myelocytes/100 leukocytes in Blood
162
836
2.05
15.04
5.5
4.3
%
0.8
0.8
0.09
41
210
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
241
1422
1.83
15.02
2.2
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
54
164
3.38
14.86
2.7
2.9
e9/l
1.6
1.4
0.40
35
95
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
96
402
2.48
14.73
2.0
1.5
g/l
1.1
1.2
0.43
91
382
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
49
141
3.56
14.64
2.6
2.8
%
9.0
10.3
0.41
28
107
(40760892) CBC W Ordered Manual Differential panel - Blood
415
2863
1.62
14.55
6.9
4.2
—
—
—
0
0
(3026782) Osmolality of Urine
319
2059
1.70
14.50
4.1
2.6
mosm/kgh2o
547.4
563.5
0.56
281
1752
(3013826) Glucose [Moles/volume] in Serum or Plasma
767
6087
1.53
14.42
6.7
5.1
mmol/l
6.2
6.3
1.08
712
5521
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
93
389
2.48
14.30
2.0
1.5
g/l
0.2
0.2
0.01
87
371
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
633
4841
1.53
14.01
11.3
7.3
mmol/l
1.2
1.2
0.48
540
4171
(3026250) Tacrolimus [Mass/volume] in Blood
30
62
4.92
13.82
38.7
35.1
ug/l
6.6
7.5
1.56
24
56
(3021440) Promyelocytes/100 leukocytes in Blood
153
798
2.02
13.77
5.7
4.4
%
0.1
0.1
0.54
39
192
(3003458) Phosphate [Moles/volume] in Serum or Plasma
237
1426
1.79
13.77
11.7
7.4
mmol/l
1.2
1.2
0.26
227
1339
(3007853) Bacteria identified in Skin by Aerobe culture
234
1403
1.79
13.76
1.8
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
176
968
1.93
13.60
4.4
2.8
g/l
9.7
10.0
0.35
164
892
(3025159) Blasts/100 leukocytes in Blood
147
762
2.03
13.46
5.7
4.5
%
0.0
0.1
1.01
36
164
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
135
3.48
13.36
2.7
2.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
64
230
2.86
13.28
5.1
3.8
%
55.9
55.3
0.14
64
230
(3012095) Magnesium [Moles/volume] in Serum or Plasma
242
1485
1.75
13.10
8.1
5.4
mmol/l
0.8
0.8
0.98
231
1397
(3030905) Polymorphonuclear cells [#/volume] in Blood
63
227
2.85
13.02
4.6
3.6
e9/l
3.9
4.0
0.08
63
227
(3026493) Urate [Moles/volume] in Serum or Plasma
330
2206
1.63
12.95
4.1
2.5
umol/l
336.4
4767.6
5.95
292
1977
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
577
4381
1.51
12.92
10.9
7.3
mmol/l
1.2
1.2
0.61
534
4032
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
416
2961
1.56
12.46
3.4
2.8
ng/l
24.1
38.6
1.11
206
1461
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
273
1761
1.67
12.26
3.7
2.6
e6/l
1.1
1.2
0.08
151
962
(3037467) Urinalysis macro (dipstick) panel - Urine
948
8030
1.48
11.93
5.4
3.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
127
652
2.03
11.93
4.3
3.5
e9/l
65.6
68.7
0.46
94
444
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
929
7846
1.48
11.80
10.2
6.2
u/l
83.5
81.9
0.27
892
7387
(3042936) Bacteria identified in Isolate by Culture
217
1330
1.74
11.73
2.3
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
374
2633
1.56
11.65
6.4
3.4
ph
7.4
7.4
0.02
87
487
(3035350) Ketones [Presence] in Urine by Test strip
715
5761
1.46
11.46
4.3
3.1
estimate
0.0
0.0
0.80
173
1097
(3033658) Prothrombin time (PT) actual/Normal
377
2673
1.55
11.33
5.8
4.7
%
92.7
92.4
0.10
364
2601
(3013707) Erythrocyte sedimentation rate by Westergren method
964
8242
1.47
11.20
5.7
3.6
mm/h
10.2
8.7
3.13
915
7704
(3017143) Hepatitis C virus Ab [Presence] in Serum
312
2127
1.59
11.12
1.9
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
415
3018
1.52
11.06
3.1
2.6
u/l
55.4
55.5
0.00
391
2807
(3012544) pH of Venous blood
198
1203
1.74
11.01
8.1
6.4
—
7.4
—
0
5
(3009261) Glucose [Presence] in Urine by Test strip
717
5809
1.45
11.01
4.3
3.1
estimate
0.0
0.0
0.21
173
1096
(3012501) Base excess in Blood by calculation
54
200
2.76
10.65
5.4
3.9
mmol/l
2.1
2.2
0.14
37
111
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
628
4986
1.44
10.63
8.6
5.6
umol/l
11.3
13.2
1.70
593
4663
(3037522) Nuclear Ab [Titer] in Serum
255
1675
1.63
10.55
1.6
1.4
titre
470.2
476.9
0.03
49
301
(3021601) Nitrite [Presence] in Urine by Test strip
709
5768
1.43
10.45
5.9
4.3
estimate
0.0
0.0
0.50
178
1133
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
258
1704
1.62
10.44
4.1
2.8
e6/l
2.5
2.7
0.13
136
909
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
43
142
3.09
10.40
2.8
3.0
e9/l
0.2
0.2
0.10
34
108
(3021447) Carbon dioxide [Partial pressure] in Venous blood
194
1194
1.72
10.29
8.2
6.4
kpa
5.8
5.8
0.13
188
1158
(3000991) Gas panel - Venous blood
181
1093
1.75
10.27
11.2
9.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
193
1189
1.71
10.19
8.2
6.4
mmol/l
1.4
1.4
0.02
155
918
(3048929) Epstein Barr virus Ab [Presence] in Serum
142
802
1.85
10.07
1.7
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
350
2500
1.52
10.01
2.6
2.1
u/l
176.9
275.7
1.35
331
2390
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
250
1658
1.61
9.91
4.2
3.5
ng/l
861.2
941.6
0.17
202
1337
(3028026) IgM [Mass/volume] in Serum or Plasma
134
749
1.87
9.82
2.7
1.9
g/l
1.4
1.2
0.37
123
701
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
36
5.33
9.65
6.6
9.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
163
975
1.75
9.55
2.2
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
77
356
2.23
9.50
2.4
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
76
351
2.23
9.40
2.0
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
166
1006
1.73
9.29
5.2
4.0
%
1.5
1.6
0.09
159
927
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
96
490
2.02
9.19
13.9
11.3
mg/l
1.3
1.1
1.67
90
465
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
51
199
2.62
9.13
2.3
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1260
11539
1.55
9.12
17.1
11.0
mmol/l
139.5
139.5
0.09
1229
11216
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
73
336
2.23
9.11
2.0
1.6
u/ml
88.2
101.5
—
9
54
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
87
431
2.08
9.03
1.7
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
162
987
1.72
8.89
2.3
1.8
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
13
18
7.28
8.85
5.9
6.9
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
13
18
7.28
8.85
6.8
7.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
41
145
2.88
8.84
2.9
3.0
e6/l
638.9
547.4
0.54
32
109
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
536
4240
1.41
8.81
2.0
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1260
11568
1.54
8.70
17.4
11.0
mmol/l
3.9
3.9
0.94
1229
11201
(3024354) Oxygen [Partial pressure] in Venous blood
172
1072
1.68
8.68
8.4
6.2
kpa
5.3
5.0
0.59
167
1040
(3029937) Albumin [Presence] in Urine by Test strip
399
3004
1.45
8.60
4.7
3.3
estimate
0.0
0.0
0.22
169
1115
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
64
287
2.28
8.51
2.1
1.7
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
13
8.52
8.47
9.9
9.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
357
2639
1.46
8.45
4.0
3.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
51
207
2.51
8.45
2.9
2.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
947
8276
1.39
8.35
3.8
3.0
u/l
39.1
36.9
0.37
908
7919
(40768804) Tissue Pathology biopsy report
514
4071
1.40
8.27
2.1
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1327
12359
1.61
8.24
17.3
10.3
mg/l
20.1
21.1
0.55
1094
9266
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1126
10146
1.43
8.23
13.4
8.5
ml/min/173m2
94.8
95.4
0.37
936
7955
(40768443) Skin Pathology biopsy report
72
344
2.15
8.22
1.4
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
115
649
1.84
8.19
8.2
5.1
ng/l
74.2
66.7
0.43
104
596
(3022948) Iron [Moles/volume] in Serum or Plasma
231
1570
1.56
8.17
3.7
2.3
umol/l
13.6
14.6
1.22
217
1465
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
147
894
1.71
8.11
8.6
6.7
mmol/l
23.9
23.7
0.46
142
847
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
83
421
2.03
8.11
1.7
1.4
u/ml
320.5
212.8
1.80
52
220
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
24
64
3.79
8.08
1.1
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
168
1061
1.66
8.05
12.7
10.9
mmol/l
24.6
24.5
0.04
168
1054
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
151
929
1.69
7.99
3.8
3.0
g/l
0.2
0.2
0.03
145
878
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
198
1305
1.60
7.99
4.0
2.4
%
23.1
23.9
0.32
173
1163
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
31
5.21
7.93
1.9
1.9
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
22
56
3.97
7.89
2.4
3.4
u/ml
1067.7
809.0
0.33
22
56
(21494814) CD8 cells/100 lymphocytes in Specimen
17
35
4.90
7.89
2.2
2.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
203
1352
1.58
7.83
1.7
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
112
636
1.82
7.82
2.4
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
783
6679
1.36
7.79
3.6
2.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
563
4562
1.37
7.78
3.5
2.4
nmol/l
75.0
71.7
2.39
525
4258
(3004789) Transferrin [Mass/volume] in Serum or Plasma
213
1437
1.56
7.77
3.8
2.3
g/l
2.5
2.5
0.06
199
1335
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
31
101
3.11
7.73
1.2
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
73
360
2.08
7.70
1.5
1.7
titre
128.0
260.0
—
5
8
(3045788) Cell count panel - Pleural fluid
17
36
4.76
7.65
1.4
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
38
140
2.76
7.64
1.7
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
44
175
2.56
7.62
2.2
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
62
288
2.20
7.61
2.2
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
402
3097
1.41
7.47
10.4
7.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
182
1196
1.59
7.43
1.8
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
49
208
2.40
7.41
5.2
2.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
443
3475
1.39
7.39
1.8
1.7
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
31
104
3.02
7.37
3.0
3.1
e6/l
352.5
334.1
0.07
20
64
(40768446) Kidney Pathology biopsy report
22
59
3.77
7.36
2.1
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
548
4452
1.36
7.34
4.3
3.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
167
2.56
7.29
1.8
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
162
1041
1.62
7.25
1.6
1.3
u/ml
289.0
212.5
0.33
151
974
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
30
100
3.04
7.21
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
30
100
3.04
7.21
1.2
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
15
30
5.04
7.19
4.9
4.8
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
30
101
3.01
7.10
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
30
101
3.01
7.10
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
30
101
3.01
7.10
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
30
101
3.01
7.10
1.2
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
51
225
2.31
7.09
1.4
1.9
g/l
0.6
0.7
0.20
34
179
(46235355) HIV 1 and 2 tests - Meaningful Use set
539
4387
1.36
7.07
2.3
2.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
200
1364
1.54
6.93
2.8
2.5
mmol/l
2.4
2.4
0.01
181
1180
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
139
872
1.65
6.84
3.3
2.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
329
2481
1.42
6.84
2.4
2.2
mg/l
1.6
1.1
0.39
245
1784
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
35
133
2.67
6.67
2.6
2.6
e6/l
693.5
764.0
—
10
35
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
48
214
2.28
6.54
1.3
1.2
u/ml
1.0
1.4
—
5
17
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
54
253
2.18
6.53
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
54
253
2.18
6.53
1.7
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
38
153
2.52
6.46
2.3
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
27
91
3.00
6.40
1.2
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
35
136
2.61
6.40
4.8
3.8
mg/l
30.6
25.2
0.36
29
107
(3034860) Kappa light chains.free [Mass/volume] in Serum
35
136
2.61
6.40
4.8
3.8
mg/l
55.0
94.6
0.37
29
108
(3036481) Cortisol [Moles/volume] in Serum or Plasma
180
1224
1.53
6.31
3.3
2.1
nmol/l
322.7
368.9
3.11
175
1142
(40767503) Oxygen content in Capillary blood by calculation
40
167
2.43
6.31
3.1
2.3
%
17.4
17.5
0.03
20
84
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
83
462
1.84
6.23
1.8
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
110
666
1.70
6.20
6.6
3.5
mmol/l
1.2
1.2
2.14
101
570
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
476
3870
1.34
6.10
4.4
3.3
u/l
31.3
30.8
0.08
457
3699
(3022145) Colonoscopy Study observation
159
1060
1.56
6.10
1.5
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
156
1037
1.56
6.06
4.8
3.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
24
78
3.11
6.05
2.5
2.5
%
43.4
45.9
—
9
22
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
35
140
2.54
6.05
1.2
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
58
3.48
6.02
2.1
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
58
289
2.05
6.01
1.3
1.2
u/ml
1.8
10.1
—
8
48
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
23
5.25
6.01
2.3
2.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
17
44
3.90
5.99
1.0
1.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
82
461
1.82
5.97
4.4
5.3
g/l
3.1
3.2
0.60
75
440
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1336
12628
1.50
5.94
12.7
8.2
u/l
29.0
27.0
0.60
1308
12248
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
32
124
2.61
5.90
1.9
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
269
2011
1.41
5.80
3.2
2.7
ug/g
131.0
100.6
0.83
220
1603
(3041096) Erythrocytes [Presence] in Urine by Automated
417
3348
1.34
5.77
3.8
2.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
98
587
1.72
5.76
2.2
1.7
—
—
—
0
0
(4062490)
35
144
2.46
5.72
1.3
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
35
144
2.46
5.72
1.3
1.4
g/l
2.1
2.6
0.78
18
108
(3024139) IgG subclass 3 [Mass/volume] in Serum
35
144
2.46
5.72
1.3
1.4
g/l
0.3
0.4
0.36
18
106
(3027135) IgG subclass 1 [Mass/volume] in Serum
35
144
2.46
5.72
1.3
1.4
g/l
6.4
6.1
0.18
18
107
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
336
2613
1.37
5.71
2.8
2.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
52
254
2.08
5.70
1.7
1.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
73
404
1.85
5.60
6.0
5.6
%
0.6
0.7
0.25
68
392
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
61
3.31
5.59
1.8
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
60
312
1.96
5.55
1.3
1.2
u/ml
39.0
47.7
—
6
18
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
153
2.39
5.50
1.9
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
111
2.64
5.49
2.0
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
56
287
1.99
5.41
1.3
1.2
u/ml
1.5
2.9
—
5
34
(3044640) Blood type and Crossmatch panel - Blood
425
3449
1.32
5.41
2.9
2.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
49
239
2.09
5.41
2.0
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
16
43
3.75
5.37
1.4
1.4
e6/l
41140.1
26758.5
—
9
26
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
56
289
1.97
5.31
2.7
2.1
g/l
1.3
1.3
0.11
51
255
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
618
5287
1.29
5.27
4.5
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
364
2902
1.34
5.21
3.1
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
419
3415
1.31
5.13
1.8
1.7
pmol/l
96.8
97.9
0.22
223
1877
(3052851) Hemolysis interference index of Serum or Plasma
57
302
1.92
5.02
2.9
2.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
66
367
1.83
5.02
3.4
2.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
82
490
1.71
4.90
1.4
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
46
3.50
4.90
1.4
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
16
46
3.50
4.90
1.4
1.3
e6/l
2722.3
2827.3
—
10
33
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
28
112
2.53
4.89
1.9
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
405
3310
1.31
4.82
2.0
1.5
g/l
1.9
2.0
1.75
261
1948
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1035
9497
1.29
4.80
4.3
3.9
pmol/l
14.6
14.4
1.25
959
8808
(3013512) EKG study
278
2153
1.36
4.80
3.6
2.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
17
53
3.23
4.62
6.1
3.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
143
991
1.49
4.61
9.7
7.2
mmol/l
1.1
1.1
0.02
108
703
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
71
415
1.75
4.60
1.8
1.6
iu/ml
97.1
0.2
—
10
87
(3009343) pH of Capillary blood
145
1009
1.48
4.58
9.6
7.1
ph
7.4
7.4
0.45
17
64
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
49
257
1.94
4.48
1.2
1.2
u/ml
16.5
22.7
—
8
23
(3019309) Folate [Moles/volume] in Red Blood Cells
177
1287
1.43
4.45
1.7
1.6
nmol/l
1169.4
1136.0
0.22
138
995
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
23
88
2.64
4.40
4.1
3.3
umol/l
25.7
27.0
0.29
23
88
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
57
317
1.83
4.37
1.8
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
101
2.50
4.31
2.4
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
22
4.57
4.30
2.3
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
389
3205
1.29
4.29
2.4
2.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
144
1015
1.46
4.27
9.8
7.1
kpa
5.0
5.1
0.43
138
960
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
140
2.24
4.20
1.2
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
41
3.44
4.19
1.4
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
237
1829
1.35
4.16
1.3
1.2
u/ml
11.6
9.5
0.16
98
743
(40760888) Immunoglobulin light chains.free panel - Serum
25
103
2.45
4.14
5.0
4.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
173
1269
1.41
4.14
5.8
3.3
umol/l
7.3
6.7
0.17
150
1063
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
422
3527
1.27
4.13
2.5
2.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
27
116
2.35
4.10
7.6
8.9
mg/l
9.9
10.1
0.09
27
107
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
61
354
1.75
4.09
2.0
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
243
1892
1.34
4.02
1.7
1.4
nmol/l
20.0
20.5
0.21
215
1653
(4035726)
107
719
1.53
4.02
1.7
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1188
11181
1.29
4.01
4.3
3.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
23
93
2.50
3.97
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
38
3.44
3.90
2.0
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
24
4.19
3.89
2.9
2.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
38
193
1.99
3.84
1.2
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
25
107
2.36
3.84
1.8
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
337
2762
1.28
3.83
2.7
2.3
mg/l
2.7
2.7
0.07
297
2402
(3020891) Body temperature
50
280
1.81
3.79
4.6
5.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
20
78
2.59
3.72
1.6
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
20
78
2.59
3.72
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
20
78
2.59
3.72
1.5
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
84
2.52
3.72
3.6
3.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1090
10187
1.25
3.69
3.5
3.1
mmol/l
1.3
1.2
0.46
1035
9638
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
12
6.69
3.67
2.4
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1176
11091
1.27
3.67
20.0
13.1
%
13.4
13.3
0.76
1158
10892
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
65
398
1.66
3.62
1.3
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
35
3.45
3.62
2.0
1.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
212
1.91
3.60
3.6
2.1
g/l
7.0
7.3
0.53
32
162
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
212
1.91
3.60
3.6
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
212
1.91
3.60
3.6
2.1
g/l
3.7
3.7
0.03
30
152
(3045142) Bone marrow Pathology biopsy report
24
104
2.33
3.60
1.3
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
68
422
1.64
3.60
13.1
14.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
109
755
1.48
3.57
1.5
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
14
46
3.06
3.53
1.4
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
14
46
3.06
3.53
1.4
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
14
46
3.06
3.53
1.4
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
14
46
3.06
3.53
1.4
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
50
287
1.77
3.52
1.5
1.5
—
—
—
0
0
(3036489) Thrombin time
81
528
1.56
3.51
3.9
4.3
s
21.5
22.2
0.63
75
468
(3012898) Urea [Moles/volume] in Urine
6
6
10.03
3.50
1.2
1.5
mmol/l
182.2
218.5
—
6
6
(3024928) Oxygen saturation in Venous blood
41
222
1.87
3.48
7.8
7.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
153
2.05
3.42
1.4
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
65
405
1.63
3.40
1.3
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
31
154
2.03
3.36
5.4
4.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
196
1.91
3.36
3.7
2.2
g/l
3.2
3.2
0.10
30
156
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
35
182
1.94
3.35
1.1
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
37
3.26
3.34
2.1
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
307
2528
1.27
3.33
1.7
1.7
mmol/l
1.5
1.4
0.55
266
2209
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
221
1744
1.31
3.33
1.7
1.6
pmol/l
49721097.1
30086006.1
0.15
179
1519
(3015235) Bicarbonate [Moles/volume] in Capillary blood
43
240
1.81
3.33
6.8
5.8
mmol/l
23.9
24.4
0.48
38
213
(4010399)
96
658
1.49
3.32
1.4
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
79
521
1.54
3.28
3.3
3.9
ng/l
95.9
156.2
2.01
72
458
(3035637) Corticotropin [Mass/volume] in Plasma
41
227
1.83
3.26
1.9
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
159
1199
1.36
3.25
1.3
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
19
4.76
3.24
2.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
65
411
1.61
3.23
1.3
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
242
1942
1.29
3.22
1.4
1.2
iu/ml
26.1
23.9
0.13
80
570
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
317
2632
1.26
3.20
1.8
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
36
193
1.89
3.17
2.3
2.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1161
10997
1.24
3.11
5.0
4.4
mu/l
1.8
2.0
0.81
1101
10369
(40761535) Cells panel - Urine sediment
97
676
1.46
3.11
4.4
3.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
70
455
1.56
3.11
2.0
2.0
u/l
34.6
40.7
2.32
62
420
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
76
505
1.53
3.06
1.9
2.2
ug/l
9.4
8.2
0.20
60
454
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
19
80
2.39
3.06
1.5
1.7
%
61.4
56.1
—
10
62
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
34
3.25
3.06
1.0
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
43
247
1.76
3.05
2.0
1.9
ug/l
1.9
2.9
0.23
37
219
(44813793)
26
126
2.08
3.03
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
97
680
1.46
3.02
3.3
2.3
ml/min/173m2
71.9
77.9
0.49
33
241
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
138
1032
1.37
2.99
2.2
2.4
u/l
45.3
79.3
0.32
116
868
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
5
10.03
2.98
1.6
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
989
9236
1.20
2.97
4.8
4.2
mmol/mol
37.3
37.7
0.59
929
8741
(40761511) CBC panel - Blood by Automated count
1347
13010
1.33
2.94
13.8
9.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1131
10706
1.22
2.93
3.9
3.4
mmol/l
4.6
4.7
0.79
1072
10180
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
82
2.33
2.92
1.2
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
135
2.02
2.91
1.8
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
684
6187
1.19
2.90
3.8
2.9
ug/l
93.6
79.4
1.22
648
5832
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
76
512
1.51
2.89
1.5
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
26
129
2.03
2.87
3.8
3.3
%
2.0
1.4
0.15
20
105
(3009871) Measles virus Ab [Titer] in Serum
12
41
2.94
2.86
1.9
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
37
208
1.80
2.84
3.1
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
223
1.77
2.83
7.3
12.0
u/ml
0.3
0.3
0.08
19
113
(3003396) Base excess in Arterial blood by calculation
113
826
1.40
2.82
9.4
10.3
mmol/l
0.4
0.9
0.76
93
648
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
213
1711
1.29
2.82
2.3
1.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
47
2.78
2.82
1.2
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
23
3.93
2.77
1.2
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
34
188
1.83
2.76
1.6
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
432
3761
1.21
2.75
1.5
1.4
u/ml
2.8
2.1
0.28
109
912
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
72
2.38
2.73
1.1
1.1
miu/ml
1635.6
1463.8
0.35
17
72
(3014148) Varicella zoster virus Ab [Titer] in Serum
45
272
1.67
2.70
1.4
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
112
824
1.39
2.70
10.9
7.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
11
37
2.99
2.69
1.2
1.1
—
28.3
—
0
6
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
20
92
2.19
2.67
1.3
1.2
u/l
110.2
121.3
0.07
13
64
(3036048) Francisella tularensis Ab [Titer] in Serum
9
24
3.77
2.67
1.1
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
103
750
1.40
2.64
14.6
15.5
inr
1.2
1.1
0.14
17
125
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1084
10256
1.20
2.64
3.9
3.3
mmol/l
5.7
5.6
0.32
1007
9535
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
44
267
1.67
2.61
2.0
2.4
ug/l
210.8
294.6
0.44
39
244
(3017732) Neutrophils [#/volume] in Blood
108
795
1.39
2.60
2.4
2.2
e9/l
4.4
4.2
0.35
94
697
(3047007) Chlamydophila sp Ab [Presence] in Serum
47
291
1.63
2.59
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1121
10646
1.21
2.59
3.8
3.3
mmol/l
1.4
1.4
1.10
1064
10072
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
38
2.91
2.58
1.5
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
38
2.91
2.58
1.5
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
38
2.91
2.58
1.5
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
258
2146
1.24
2.55
2.4
2.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
6
11
5.47
2.54
1.3
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
21
101
2.09
2.53
10.0
12.8
%
12.4
11.8
0.38
21
101
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
101
2.09
2.53
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
339
2904
1.22
2.53
1.8
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1133
10782
1.20
2.50
4.1
3.6
mmol/l
2.8
2.8
0.75
1069
10165
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
47
294
1.62
2.50
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
47
294
1.62
2.50
2.6
2.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
20
95
2.12
2.49
1.9
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
26
3.48
2.48
6.0
6.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
41
248
1.67
2.48
1.1
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
82
2.21
2.48
2.3
1.8
mg/l
13.2
19.5
—
5
27
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
18
82
2.21
2.48
2.7
1.6
pg
31.7
32.3
0.24
18
82
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
11
39
2.83
2.47
1.2
1.4
u/l
827.5
312.8
0.69
11
39
(3004716) Salmonella sp identified in Stool by Organism specific culture
124
943
1.34
2.45
1.3
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
108
805
1.37
2.43
2.8
3.4
pmol/l
4.8
4.7
0.31
91
727
(3003740) Influenza virus B Ag [Presence] in Specimen
55
360
1.55
2.43
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
138
1.90
2.42
4.2
3.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
61
410
1.51
2.39
4.1
7.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
90
2.13
2.39
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
65
443
1.49
2.39
8.5
4.8
g/l
0.5
0.3
0.53
47
246
(3019150) Specific gravity of Urine by Refractometry
300
2554
1.22
2.38
4.3
3.3
kg/l
1.0
1.0
0.11
42
390
(3002523) Influenza virus A Ag [Presence] in Specimen
55
362
1.54
2.38
1.1
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
8
6.27
2.37
1.0
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
9
28
3.23
2.31
1.2
1.3
—
8.2
—
0
6
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
198
1618
1.26
2.30
3.8
3.2
ng/l
549.7
600.7
0.06
125
987
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
14
59
2.39
2.29
1.4
1.2
—
1.8
—
0
5
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
31
178
1.76
2.27
1.6
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
120
1.93
2.26
1.6
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
73
516
1.44
2.25
1.3
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
15
66
2.29
2.24
1.7
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
331
2867
1.20
2.19
4.9
3.7
mmol/l
8.2
8.3
0.14
293
2492
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
34
203
1.69
2.19
1.6
2.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
48
2.51
2.18
1.3
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
109
829
1.34
2.18
2.3
2.3
au/ml
17.0
24.4
—
7
61
(3019225) pH of Specimen
98
736
1.35
2.13
4.4
3.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
67
472
1.44
2.11
1.6
1.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
68
2.22
2.11
2.1
1.5
u/l
2.7
6.5
—
10
31
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
24
131
1.85
2.08
1.8
1.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
14
62
2.27
2.08
1.4
1.2
—
40.7
—
0
6
(3000570) Elastase.pancreatic [Mass/mass] in Stool
47
309
1.54
2.07
1.5
1.4
ug/g
325.7
351.0
0.35
26
160
(3051611) Lipemic interference index of Serum or Plasma
20
103
1.95
2.05
4.4
3.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
56
2.33
2.05
1.3
1.6
%
37.0
36.5
—
5
39
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
23
125
1.85
2.03
2.2
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
156
1260
1.27
2.01
3.0
2.4
u/l
7226.6
5115.0
0.23
62
489
(3024932) HLA-DR beta [Type]
14
63
2.23
2.01
1.1
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
14
63
2.23
2.01
1.4
1.2
—
75.3
—
0
7
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
10
38
2.64
2.01
4.5
3.1
ug/l
110.4
125.4
—
10
38
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
38
2.64
2.01
3.0
2.7
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
47
312
1.52
2.00
2.6
2.5
e6/l
593.5
1140.8
0.30
37
251
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
47
312
1.52
2.00
2.6
2.4
e6/l
3.3
16.1
1.12
34
242
(44790049)
31
186
1.68
1.98
2.6
1.7
—
—
—
0
0
(44790047)
31
186
1.68
1.98
2.6
1.7
—
—
—
0
0
(44790048)
31
186
1.68
1.98
2.6
1.7
—
—
—
0
0
(44806118)
31
186
1.68
1.98
2.6
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
21
3.34
1.96
1.6
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
14
64
2.20
1.94
1.0
1.0
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
14
64
2.20
1.94
1.4
1.3
—
67.3
—
0
10
(3000492) Spirometry study
149
1203
1.26
1.94
1.6
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
155
1260
1.26
1.91
1.3
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
7
22
3.19
1.88
1.1
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1442
14174
1.38
1.88
24.0
15.4
e9/l
6.8
6.8
0.76
1418
13787
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
291
2526
1.19
1.87
1.7
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
227
1927
1.21
1.86
1.7
1.7
%
1.3
1.4
0.94
202
1757
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
107
1.88
1.86
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
28
2.87
1.86
1.3
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
1441
14165
1.37
1.85
23.8
15.2
pg
29.9
29.8
0.65
1429
14017
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
167
1.69
1.84
7.3
2.9
—
—
—
0
0
(3024731) MCV [Entitic volume]
1441
14166
1.37
1.84
23.8
15.3
fl
89.3
89.0
1.08
1429
14020
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
123
978
1.28
1.82
2.3
2.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1441
14168
1.37
1.82
23.9
15.3
e12/l
4.6
4.6
0.89
1414
13785
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
119
943
1.28
1.81
4.8
5.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1439
14146
1.36
1.81
24.0
15.4
e9/l
262.4
261.1
0.31
1416
13785
(3000475) Leukocytes [#/volume] in Synovial fluid
28
170
1.66
1.74
1.8
1.7
e6/l
10857.7
14129.7
0.29
20
131
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
12
54
2.23
1.74
1.3
2.2
umol/l
14.0
15.6
0.28
12
54
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
125
1.77
1.72
1.3
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1441
14177
1.35
1.72
24.1
15.4
g/l
135.9
136.4
0.62
1429
14028
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
61
2.14
1.71
1.7
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
94
728
1.31
1.71
1.7
1.6
u/l
7.9
7.9
0.00
72
550
(3006653) Thiamine [Moles/volume] in Blood
11
48
2.30
1.70
1.7
1.5
nmol/l
138.5
146.1
0.22
11
48
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
118
1.79
1.70
1.2
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
118
1.79
1.70
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
119
1.78
1.66
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
119
1.78
1.66
1.2
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
119
1.78
1.66
1.2
1.4
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
6
19
3.17
1.66
2.8
3.5
mg/l
2.4
4.0
—
6
19
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
120
1.76
1.62
1.2
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
120
1.76
1.62
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
238
1.53
1.61
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
20
113
1.78
1.60
1.3
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
97
762
1.29
1.60
1.3
1.2
—
39.0
—
0
31
(3051651) Icteric interference index of Serum or Plasma
16
84
1.91
1.60
4.8
3.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
26
2.70
1.58
1.4
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
33
215
1.55
1.57
1.4
1.3
u/ml
2.8
6.4
1.03
15
80
(3011288) Drugs identified in Urine by Screen method
106
845
1.27
1.57
3.0
3.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
50
2.21
1.57
8.5
7.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
28
176
1.60
1.55
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
15
78
1.93
1.54
1.0
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
8
33
2.43
1.54
1.3
1.1
—
14.1
—
0
7
(3044941) Cell count panel - Synovial fluid
20
115
1.75
1.53
1.5
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
27
2.60
1.51
3.1
6.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
25
154
1.63
1.50
2.2
2.6
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
23
140
1.65
1.45
6.2
3.1
mmol/l
1.4
1.5
0.49
23
134
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
117
1.72
1.45
1.3
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
18
102
1.77
1.45
1.6
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
80
1.88
1.45
1.1
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
52
2.12
1.44
1.9
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
118
1.70
1.41
1.3
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
7
29
2.42
1.39
1.1
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
32
214
1.51
1.39
1.4
1.3
u/ml
4.0
5.4
0.43
17
97
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
67
1.95
1.38
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
60
2.01
1.38
1.8
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
69
530
1.32
1.38
1.5
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
75
583
1.30
1.37
1.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
27
174
1.56
1.37
1.4
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
23
2.61
1.37
5.7
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
227
1987
1.17
1.35
4.2
3.5
mg/l
561.5
326.0
0.30
164
1344
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
136
1140
1.21
1.32
1.3
1.2
iu/ml
152.4
144.4
0.06
46
431
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
43
2.10
1.30
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
76
1.85
1.30
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
26
169
1.55
1.29
3.5
3.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
55
2.01
1.27
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
44
2.05
1.27
1.1
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
37
261
1.43
1.25
1.5
1.4
u/l
10.1
13.5
0.56
32
221
(21494434) Karyotype in Bone marrow
14
77
1.83
1.25
1.3
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
14
77
1.83
1.25
2.4
1.9
—
—
—
0
0
(4281824)
14
77
1.83
1.25
1.3
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
36
2.23
1.24
1.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
36
2.23
1.24
1.4
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
45
2.01
1.23
1.1
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
45
2.01
1.23
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
19
116
1.65
1.21
1.5
1.8
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
37
2.17
1.21
1.4
1.3
—
—
—
0
0
(1002224) Polysomnography panel
68
533
1.29
1.20
1.1
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
17
101
1.69
1.20
1.2
1.5
umol/l
10.3
10.2
0.02
17
94
(3027944) Amphetamines [Presence] in Urine
142
1209
1.19
1.19
2.1
2.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
6
26
2.31
1.18
1.2
1.0
ng/l
29.8
34.7
—
6
16
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
6
26
2.31
1.18
1.2
1.0
ng/l
266.7
257.5
—
6
17
(3013139) Helicobacter pylori Ag [Presence] in Stool
89
723
1.25
1.18
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
144
1229
1.19
1.17
2.2
2.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
16
94
1.71
1.17
1.2
1.5
mmol/l
1.8
1.7
0.00
16
89
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
106
879
1.22
1.17
1.8
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
110
1.64
1.15
1.7
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
20
2.50
1.15
1.8
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
118
991
1.21
1.15
2.8
2.2
nmol/l
12.3
12.4
0.02
108
882
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
65
1.85
1.13
2.3
3.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
86
701
1.24
1.12
2.7
2.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
21
2.39
1.09
1.6
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
41
1.96
1.09
1.6
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
41
1.96
1.09
1.6
1.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
8
41
1.96
1.09
1.0
1.1
—
84.4
—
0
11
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
41
1.96
1.09
1.6
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
8
41
1.96
1.09
1.0
1.2
—
71.4
—
0
11
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
20
128
1.57
1.08
1.3
1.4
nmol/l
—
0.6
—
0
5
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
32
2.19
1.08
1.4
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
32
2.19
1.08
3.4
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
31
219
1.42
1.07
1.2
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
74
1.76
1.07
3.6
2.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
143
1233
1.18
1.05
2.3
2.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
82
1.71
1.05
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
30
212
1.42
1.04
1.4
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
46
1.96
1.03
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
46
1.96
1.03
1.1
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
22
2.28
1.03
2.4
2.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
34
2.06
1.03
1.3
1.4
ug/l
10.3
9.2
—
7
34
(3020682) Albumin/Creatinine [Ratio] in Urine
232
2080
1.14
1.02
5.0
4.3
mg/mmol
15.6
18.1
0.11
167
1388
(3017354) Segmented neutrophils/100 leukocytes in Blood
14
83
1.69
1.01
3.6
3.0
%
44.6
56.1
—
9
58
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
48
1.88
1.00
2.1
1.2
u/l
858.3
421.3
—
9
41
(3006184) Hemoglobin [Mass/volume] in Capillary blood
29
206
1.42
0.99
2.9
2.3
g/l
133.7
134.2
0.04
24
157
(3000764) Benzodiazepines [Presence] in Urine
141
1223
1.17
0.98
2.2
2.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22
148
1.49
0.98
1.0
1.0
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
29
0.00
0.97
0.0
1.0
—
4.5
—
0
22
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
92
1.64
0.97
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
69
1.75
0.96
1.2
1.1
iu/ml
379.5
213.0
0.34
12
69
(3032868) Hemoglobin electrophoresis panel in Blood
0
31
0.00
0.96
0.0
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22
149
1.48
0.95
1.2
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
13
77
1.69
0.95
3.6
2.3
mmol/l
107.9
105.7
1.96
13
77
(3021387) Prolactin [Units/volume] in Serum or Plasma
108
919
1.19
0.95
2.2
1.6
mu/l
335.8
305.5
0.37
100
826
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
85
1.65
0.94
1.4
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
58
463
1.26
0.93
2.1
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
6
27
2.23
0.93
1.5
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
52
1.74
0.92
2.0
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
132
1146
1.17
0.92
2.3
2.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
13
78
1.67
0.91
3.6
2.2
mmol/l
4.1
4.0
0.93
13
78
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
86
1.63
0.91
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
86
1.63
0.91
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
17
110
1.55
0.90
1.6
1.1
—
—
—
0
0
(4306422)
29
210
1.39
0.90
1.2
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
6
29
2.07
0.89
1.8
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
8
42
1.91
0.88
1.6
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
18
119
1.52
0.88
1.1
1.4
promille
1.6
1.4
0.17
13
94
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
43
1.86
0.87
1.6
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
41
318
1.30
0.84
1.6
1.3
—
1232.0
—
0
5
(3025130) Human papilloma virus identified in Specimen
31
231
1.35
0.83
2.4
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
158
1403
1.14
0.83
1.2
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
21
146
1.44
0.82
1.1
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
73
1.65
0.81
1.3
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
33
1.82
0.79
3.0
2.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
52
423
1.24
0.75
1.1
1.1
u/ml
8.5
4.7
0.41
19
196
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
67
1.65
0.75
1.9
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
449
4238
1.08
0.75
1.6
1.7
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
13
83
1.57
0.75
1.4
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
24
2.09
0.74
1.2
1.7
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
25
2.00
0.72
1.2
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
17
117
1.46
0.72
1.6
1.4
pmol/l
294.8
354.5
0.20
11
91
(3013336) Amino acids [Identifier] in Serum or Plasma
7
41
1.71
0.70
2.6
2.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
38
301
1.27
0.69
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
30
230
1.31
0.69
4.6
3.3
mg/l
24.0
25.8
0.12
21
142
(3028707) Methadone [Presence] in Urine by Screen method
65
547
1.20
0.69
3.3
3.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
49
403
1.22
0.66
2.4
2.3
—
—
—
0
0
(3049233) Organic acids panel - Urine
5
28
1.79
0.66
2.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
130
1449
0.89
0.64
1.6
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.0
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
29
1.73
0.64
1.2
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
85
740
1.16
0.62
1.4
1.3
miu/ml
248.9
233.7
0.13
38
380
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
105
0.57
0.61
1.2
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
8
50
1.60
0.61
1.1
1.1
u/l
20.2
30.4
—
8
36
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
8
50
1.60
0.61
1.1
1.1
u/l
94.9
96.6
—
8
38
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
51
1.57
0.60
1.3
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
52
1.54
0.59
2.4
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
24
184
1.31
0.58
3.5
3.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
15
106
1.42
0.57
4.3
2.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
35
1.72
0.57
1.2
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
14
98
1.43
0.56
5.1
4.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
28
221
1.27
0.55
1.7
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
23
177
1.30
0.54
4.3
3.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
186
1716
1.10
0.54
3.5
3.6
ug/l
1.6
2.0
0.91
168
1572
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
82
1.47
0.54
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
38
1.58
0.54
4.0
3.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
6
40
1.50
0.51
1.8
1.5
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
34
278
1.23
0.51
4.2
3.4
nmol/l
27.1
22.1
1.08
34
272
(40768800) Prostate Pathology biopsy report
9
65
1.39
0.50
1.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
74
651
1.14
0.50
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
31
252
1.23
0.50
1.6
1.6
mmol/l
7.1
7.4
0.40
25
146
(3035933) Granulocytes/100 leukocytes in Blood
17
127
1.34
0.49
1.5
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
32
389
0.82
0.49
1.4
1.6
—
—
—
0
0
(4094501)
24
190
1.27
0.48
1.3
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
107
969
1.11
0.47
3.5
3.3
%
30.7
31.3
0.24
84
719
(3036071) Salmonella sp Ab [Titer] in Serum
10
68
1.47
0.47
1.0
1.1
—
—
—
0
0
(4024509)
10
68
1.47
0.47
1.6
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
48
1.46
0.46
1.1
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
40
337
1.19
0.46
1.3
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1257
12420
1.07
0.45
17.6
11.7
%
40.0
40.4
1.13
1050
10429
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
19
147
1.30
0.45
1.1
1.1
%
103.9
92.3
1.10
19
138
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
77
862
0.89
0.45
1.5
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
69
1.45
0.44
1.4
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
77
861
0.89
0.44
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
77
860
0.89
0.43
1.4
1.4
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
31
1.61
0.43
1.8
1.8
—
17.6
—
0
12
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
70
1.43
0.41
1.5
1.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
77
857
0.89
0.41
1.5
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
16
123
1.30
0.40
1.8
5.5
mmol/l
7.4
6.6
0.43
16
101
(4146454)
8
61
1.31
0.39
2.0
3.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
35
1.43
0.39
1.4
1.3
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
19
0.00
0.39
0.0
1.2
—
0.4
—
0
13
(3000330) Specific gravity of Urine by Test strip
49
429
1.15
0.38
4.3
2.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
66
1.37
0.38
1.9
3.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
66
1.37
0.38
1.9
3.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
162
1515
1.08
0.38
1.8
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
97
888
1.10
0.37
2.0
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
59
525
1.13
0.37
1.3
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
38
439
0.86
0.36
1.6
1.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
17
211
0.80
0.34
1.4
1.3
u/ml
1.6
9.9
—
9
104
(3050129) First trimester maternal screen panel - Serum or Plasma
101
1093
0.92
0.34
1.4
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
74
1.35
0.32
1.9
1.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
10
74
1.35
0.32
1.3
1.1
—
4.5
—
0
15
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
229
1.18
0.32
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
87
945
0.92
0.32
1.5
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
12
92
1.31
0.32
1.0
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
101
937
1.08
0.31
1.6
1.5
iu/l
20.5
17.3
0.45
85
742
(3020876) Protein [Mass/time] in 24 hour Urine
7
53
1.32
0.31
2.0
2.0
—
2.8
—
0
5
(3043238) Trisomy 21 risk [Likelihood] in Fetus
66
724
0.91
0.30
1.5
1.5
—
—
—
0
0
(4034850)
36
315
1.15
0.30
10.5
8.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
63
573
1.10
0.29
3.8
4.3
ug/l
13.8
15.2
0.04
46
438
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
14
112
1.25
0.28
1.1
1.3
pmol/l
118.0
51.3
—
5
33
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
159
1674
0.94
0.27
1.5
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
39
347
1.13
0.27
1.7
2.0
iu/l
4.0
5.2
0.42
13
135
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
66
1.21
0.26
1.9
1.5
%
—
67.4
—
0
9
(3047352) Trisomy 18 risk [Likelihood] in Fetus
65
706
0.92
0.26
1.5
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
9
74
1.22
0.25
1.6
3.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
114
1.23
0.25
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
43
388
1.11
0.24
1.1
1.1
u/ml
5.7
6.2
0.06
22
194
(3005033) Fetal Nuchal fold Thickness US
65
703
0.92
0.24
1.5
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
38
1.32
0.23
1.0
1.3
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
5
39
1.28
0.23
1.0
1.1
u/ml
0.5
1.8
—
5
31
(1761868) Lipid panel - Serum or Plasma
449
4387
1.03
0.22
2.4
2.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
23
200
1.15
0.22
1.3
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
28
248
1.13
0.21
3.0
1.9
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
11
0.00
0.21
0.0
1.0
—
22.0
—
0
6
(44806420)
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
1.9
—
0
12
(3051339) Copper [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.2
—
15.5
—
0
13
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
10.6
—
0
13
(3044009) aPTT.lupus sensitive (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
117
1.20
0.20
1.5
1.4
nmol/l
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
32
355
0.90
0.20
1.7
1.9
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
48
1.25
0.20
1.2
1.0
u/ml
47.9
46.7
—
6
48
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
42
384
1.10
0.20
1.4
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
10
122
0.82
0.19
1.1
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
61
652
0.93
0.18
1.4
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
53
493
1.08
0.18
1.7
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
59
1.19
0.18
1.6
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
19
166
1.15
0.18
2.5
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
11
91
1.21
0.17
1.3
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
61
1.15
0.17
1.6
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
40
368
1.09
0.17
1.1
1.1
u/ml
0.3
0.4
0.57
13
123
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
65
611
1.07
0.17
1.2
1.2
u/ml
0.5
2.5
3.36
30
316
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
19
167
1.14
0.17
3.4
2.6
ug/min
35.8
152.0
1.56
12
108
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
24
267
0.90
0.16
1.0
1.0
u/ml
1.4
3.1
—
7
128
(4268621)
17
149
1.14
0.15
2.5
2.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
79
0.76
0.15
9.0
5.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
79
0.76
0.15
4.5
2.8
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
6
79
0.76
0.15
1.2
1.2
u/ml
6.7
14.8
—
6
71
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
6
79
0.76
0.15
1.2
1.2
u/ml
0.9
5.7
—
6
68
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
68
717
0.95
0.15
1.6
2.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
83
1.08
0.14
4.0
2.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
26
237
1.10
0.14
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
174
1788
0.97
0.13
1.3
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
32
297
1.08
0.12
1.6
1.4
pmol/l
71.0
121.4
0.62
32
286
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
38
404
0.94
0.11
1.2
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
39
414
0.94
0.11
1.4
1.3
ug/l
3.3
3.6
0.23
32
389
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
33
309
1.07
0.10
1.4
1.4
nmol/l
0.3
0.4
0.11
26
262
(4027681)
13
115
1.13
0.10
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
98
1010
0.97
0.09
1.3
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
27
252
1.07
0.09
1.3
1.1
iu/ml
6.0
1736.2
—
10
78
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
1.0
1.7
nmol/l
2.0
1.2
—
5
39
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
24
223
1.08
0.09
1.2
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
155
0.90
0.09
1.3
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
58
1.03
0.08
1.3
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
62
0.81
0.08
1.2
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
62
0.81
0.08
1.4
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
60
622
0.96
0.08
1.6
1.6
mg/l
5.9
3.7
0.36
49
421
(3010726) Horse dander IgE Ab [Units/volume] in Serum
53
550
0.96
0.07
1.3
1.1
u/ml
6.9
2.7
0.43
15
174
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
72
742
0.97
0.07
1.8
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
137
1343
1.02
0.07
3.4
3.3
%
22.5
21.3
0.40
47
465
(3003338) MCHC [Mass/volume]
1163
11667
0.99
0.07
19.9
13.2
g/l
334.2
334.1
0.19
1154
11575
(3023511) Choriogonadotropin [Units/volume] in Urine
69
672
1.03
0.05
1.5
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
129
1.09
0.05
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
83
812
1.02
0.05
1.5
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
58
564
1.03
0.05
1.2
1.1
u/ml
6.8
6.1
0.09
32
364
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
120
0.92
0.05
1.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
109
1073
1.02
0.04
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
170
1.06
0.04
1.3
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
13
121
1.08
0.03
13.9
11.9
mmol/l
0.5
0.6
1.25
13
111
(3020874) Milk IgE Ab [Units/volume] in Serum
22
210
1.05
0.03
1.4
1.4
u/ml
0.4
2.8
1.88
14
110
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
131
1.07
0.03
1.6
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
101
998
1.01
0.02
2.6
2.4
ug/l
0.6
0.7
0.76
53
512
(3008401) Mugwort IgE Ab [Units/volume] in Serum
54
548
0.98
0.01
1.2
1.1
u/ml
0.8
1.4
0.42
25
303
(3034274) Bile acid [Moles/volume] in Serum --fasting
39
397
0.98
0.01
5.2
2.6
umol/l
7.7
6.6
0.35
31
311
(3006598) pH of Arterial cord blood
15
144
1.04
0.00
1.0
1.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
12
116
1.03
0.00
1.2
1.3
u/ml
0.5
22.9
—
7
92
(4198724)
12
124
0.97
0.00
1.3
3.8
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
18
178
1.01
0.00
1.1
1.2
u/ml
0.2
3.0
—
5
42
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
30.8
—
0
5
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
5
54
0.93
0.00
1.0
1.1
—
7.6
—
0
29
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
187.3
—
0
6
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
17
170
1.00
0.00
1.4
1.6
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
5
54
0.93
0.00
1.0
1.1
—
3.2
—
0
29
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
5.6
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
19.9
—
0
5
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
5.5
—
0
6
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
2.7
—
6.9
—
0
7
(3041806) Other cells [#/volume] in Blood by Manual count
14
140
1.00
0.00
1.9
1.6
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
261.7
—
0
7
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
57
0.88
0.00
1.0
1.0
g/l
175.0
164.5
—
5
57
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_VIRAL_SKIN_NOS and mortality.

Females

Parameter HR [95% CI] p-value
AB1_VIRAL_SKIN_NOS 1.294 [0.99, 1.68] 0.055
Birth year 0.991 [0.98, 1.0] 0.042

During the follow-up period (1.1.1998 — 31.12.2019), 151 out of 9236 females with AB1_VIRAL_SKIN_NOS died.

Males

Parameter HR [95% CI] p-value
AB1_VIRAL_SKIN_NOS 1.53 [1.19, 1.97] 0.001
Birth year 0.987 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 183 out of 9318 males with AB1_VIRAL_SKIN_NOS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_VIRAL_SKIN_NOS.

N-year risk Females Males
1 0.102% 0.274%
5 0.692% 1.95%
10 1.648% 4.642%
15 3.33% 8.646%
20 5.563% 14.317%

Relationships between endpoints

↥

Index endpoint: AB1_VIRAL_SKIN_NOS – Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data